Document Detail


Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
MedLine Citation:
PMID:  17400208     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
5-hydroxytryptamine (5-HT) syndrome is a dangerous condition of 5-HT excess that can occur during co-administration of a monoamine oxidase (MAO) inhibitor and an antidepressant. We investigated the effects of acute administration of MAO inhibitors and subchronic administration of tricyclic and heterocyclic antidepressants, and a serotonin-noradrenaline reuptake inhibitor (SNRI) on 5-HT syndrome in rats treated with 5-hydroxytryptophan (5-HTP). The irreversible and non-selective MAO inhibitor pargyline, and the reversible and selective MAO-A inhibitor clorgyline, produced increases in 5-HT syndrome in the 5-HTP-treated rats, while subchronic co-administration of imipramine partly intensified and partly attenuated the syndrome, whereas milnacipran only attenuated the syndrome. Co-administration of mianserin partly intensified and partly attenuated the syndrome but the attenuating effect was dominant. Administration of the irreversible and selective MAO-B inhibitor selegiline did not produce any increase in 5-HT syndrome in the 5-HTP-treated rats, compared with the saline control. These data suggest that non-selective MAO and selective MAO-A inhibitors can induce 5-HT syndrome in humans when co-administered with antidepressants. Furthermore, the risk of 5-HT syndrome may be lower with the selective MAO-B inhibitor selegiline.
Authors:
Takeshi Izumi; Nobuyuki Iwamoto; Yuji Kitaichi; Akiko Kato; Takeshi Inoue; Tsukasa Koyama
Related Documents :
4429938 - Acute emphysematous cholecystitis.
11372968 - Antennal sensilla patterns indicate geographic and ecotopic variability among triatoma ...
22140378 - Foxd1 duplication causes branchial defects and interacts with the tfap2a gene implicate...
17349098 - Idiopathic, inflammatory, medial meatal, fibrotising otitis presenting with lichen planus.
10684778 - Application of cross-impact analysis to the relationship between aldehyde dehydrogenase...
22321208 - Continuous venovenous hemofiltration and hemoperfusion in successful treatment of a pat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-03-12
Journal Detail:
Title:  European journal of pharmacology     Volume:  565     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-28     Completed Date:  2007-07-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  105-12     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Sapporo 060-8638, Japan. psyizumi@med.hokudai.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5-Hydroxytryptophan / pharmacology
Animals
Antidepressive Agents / pharmacology*
Cyclopropanes / pharmacology
Drug Interactions
Imipramine / pharmacology
Male
Mianserin / pharmacology
Monoamine Oxidase Inhibitors / pharmacology*
Rats
Rats, Sprague-Dawley
Serotonin / secretion*
Serotonin Syndrome / chemically induced*
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Cyclopropanes; 0/Monoamine Oxidase Inhibitors; 24219-97-4/Mianserin; 50-49-7/Imipramine; 50-67-9/Serotonin; 56-69-9/5-Hydroxytryptophan; 92623-85-3/milnacipran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Introduction of antisense oligonucleotides to heat shock protein 47 prevents pulmonary fibrosis in l...
Next Document:  Sympathetic nervous system mediates surgical trauma stress-induced splenocyte apoptosis in rats.